Status: Recruiting
A Study to Evaluate Safety, Tolerability and Pharmacokinetics of Orally Administered TIX100 in Healthy Subjects
Randomized, Placebo-controlled Study to determine the safety and tolerability of multiple oral doses of TIX100 administered daily for 28 days to otherwise healthy overweight/obese subjects.
Participants needed: 18
Trial details
Phase: Phase 1Age: 18-70Biological sex: AllType: InterventionalSponsor: TIXiMED, Inc.Updated: Jun 30, 2026Locations: 1
Eligibility criteria
Subjects aged 18-70 years, both genders. [+8]
History of excessive alcohol use (defined as >21 drinks per week for males and >... [+13]